Global Canine Atopic Dermatitis Market, By Therapy (Immunotherapy, Cyclosporine, Oclacitinib, Canine Atopic Dermatitis Immunotherapeutic (CADI), Others), Route of Administration (Oral, Injectable, Topical), Distribution Channel (Veterinary Hospitals, Pet Clinics, Pharmacies and Drugstores, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Canine Atopic Dermatitis Market
Data Bridge Market Research analyses that the canine atopic dermatitis is growing at a CAGR of 9.15% in the forecast period of 2022-2029.
Canine atopic dermatitis (CAD), refers to a skin condition that's a hereditary predisposition to develop pruritic inflammatory skin condition related to immune globulin antibodies, which generally target environmental allergens. The wellness generally affects dogs aged six months to a few years and is characterised by itching and secondary skin lesions of a characteristic distribution round the face (mouth, eyes), saclike side of the ear pinnae, ventral abdomen, flexor muscle aspects of the elbow, carpal, and tarsal joints, interdigital skin, and area.
The rise in prevalence of canine atopic dermatitis is the major factor accelerating the growth of the canine atopic dermatitis market. Furthermore, rise in awareness about early signs, symptoms of allergic reaction in animals, development of advanced therapeutic methods to control symptoms and rise in pollution associated with allergens level are also expected to drive the growth of the canine atopic dermatitis market. However, improper management of canine atopic dermatitis in terms of dosage, administration of drugs, and drug combination restrains the canine atopic dermatitis market, whereas, several drugs cause serious adverse reactions which can further alleviate allergic reaction will challenge market growth.
In addition, gold standard for allergy therapy and injectable will create ample opportunities for the canine atopic dermatitis market.
This canine atopic dermatitis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on canine atopic dermatitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Canine Atopic Dermatitis Market Scope and Market Size
The canine atopic dermatitis market is segmented on the basis of therapy, route of administration and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of therapy, the canine atopic dermatitis market is segmented into immunotherapy, cyclosporine, oclacitinib, canine atopic dermatitis immunotherapeutic (CADI), others.
- On the basis of route of administration, the canine atopic dermatitis market is segmented into oral, injectable, topical.
- On the basis of distribution channel, the canine atopic dermatitis market is segmented into veterinary hospitals, pet clinics, pharmacies and drugstores, others.
Canine Atopic Dermatitis Market Country Level Analysis
The canine atopic dermatitis market is analysed and market size insights and trends are provided by country, therapy, and route of administration and distribution channel as referenced above.
The countries covered in the canine atopic dermatitis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the canine atopic dermatitis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the increasing incidence of canine atopic dermatitis in pet dogs, new product launches, and growing concern among pet owners in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the growing disposable income increases the probability of higher adoption of companion animals in this region.
The country section of the canine atopic dermatitis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The canine atopic dermatitis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for canine atopic dermatitis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the canine atopic dermatitis market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Canine Atopic Dermatitis Market Share Analysis
The canine atopic dermatitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to canine atopic dermatitis market.
Some of the major players operating in the canine atopic dermatitis market report are Boehringer Ingelheim International GmbH, ALLERGAN, Bayer AG, Bristol-Myers Squibb Company, Novartis AG, LEO Pharma A/S, Regeneron, Astellas Pharma Inc., Pfizer Inc., Galderma Laboratories, L.P., Sanofi, F. Hoffmann-La Roche Ltd, Encore Dermatology, Inc., GlaxoSmithKline plc, AstraZeneca, Bausch Health among other
SKU-